Forecast & Rating2 analysts currently cover Obsidian Therapeutics, of which 2 give a positive rating. The average price target is $42.00, about 110.5% upside from the current price of $19.95. Coverage is limited, so the data is for reference only. Data as of Aug 8, 2026; this does not constitute investment advice.
Aug 6, 2026Price forecast
$42.00110.53%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 17, 2026
Forecast met0.0%
Stock price$19.95
Avg. target$42.0
High target$42
Low target$42
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.